MCID: CRV045
MIFTS: 43

Cervical Intraepithelial Neoplasia

Categories: Rare diseases

Aliases & Classifications for Cervical Intraepithelial Neoplasia

MalaCards integrated aliases for Cervical Intraepithelial Neoplasia:

Name: Cervical Intraepithelial Neoplasia 49 51 69
Cin 44

Classifications:



External Ids:

UMLS 69 C0206708

Summaries for Cervical Intraepithelial Neoplasia

MalaCards based summary : Cervical Intraepithelial Neoplasia, also known as cin, is related to cervix uteri carcinoma in situ and suppressor of tumorigenicity 3. An important gene associated with Cervical Intraepithelial Neoplasia is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), and among its related pathways/superpathways are Pathways in cancer and Validated targets of C-MYC transcriptional activation. The drugs Epinephrine and Bupivacaine have been mentioned in the context of this disorder. Affiliated tissues include testes, cervix and t cells, and related phenotypes are Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) and mortality/aging

Related Diseases for Cervical Intraepithelial Neoplasia

Diseases related to Cervical Intraepithelial Neoplasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 94)
# Related Disease Score Top Affiliating Genes
1 cervix uteri carcinoma in situ 33.1 CDKN2A FHIT KRT17
2 suppressor of tumorigenicity 3 31.0 CDKN2A FHIT
3 papilloma 30.6 CDKN2A KRT8 ODC1
4 bowenoid papulosis 30.5 CDKN2A TERT
5 cervical squamous cell carcinoma 30.5 CDKN2A KRT17 KRT8 MKI67
6 squamous cell carcinoma 30.4 CDKN2A FHIT MKI67 NME1
7 cervical cancer 30.1 BIRC5 CDKN2A FHIT TERC TERT VEGFC
8 cervicitis 11.3
9 spitz nevus 10.5 CDKN2A MKI67
10 squamous cell carcinoma of the larynx 10.5 CDKN2A MKI67
11 ameloblastic carcinoma 10.5 CDKN2A MKI67
12 endometrial mucinous adenocarcinoma 10.5 CDKN2A MKI67
13 dyskeratosis congenita, autosomal dominant 1 10.5 TERC TERT
14 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 10.5 TERC TERT
15 inherited bone marrow failure syndromes 10.5 TERC TERT
16 malignant peritoneal mesothelioma 10.4 BIRC5 CDKN2A
17 oral leukoplakia 10.4 CDKN2A MKI67
18 acral lentiginous melanoma 10.4 CDKN2A TERT
19 bowen's disease 10.4 KRT17 MKI67
20 aging 10.4
21 infiltrating angiolipoma 10.4 CDKN2A VEGFC
22 anal canal carcinoma 10.4 CDKN2A NME1
23 surfactant metabolism dysfunction, pulmonary, 1 10.4
24 surfactant metabolism dysfunction, pulmonary, 4 10.4
25 surfactant metabolism dysfunction, pulmonary, 3 10.4
26 dyskeratosis congenita autosomal dominant 10.4 TERC TERT
27 pleomorphic liposarcoma 10.4 CDKN2A KRT8
28 cryptogenic cirrhosis 10.4 KRT8 MTHFR
29 soft tissue sarcoma 10.4 MKI67 TERT
30 vaginitis 10.4
31 cervical clear cell adenocarcinoma 10.3 CDKN2A KRT8
32 mesenteric vascular occlusion 10.3 MTHFR ODC1
33 adenocarcinoma 10.3
34 necrotizing sialometaplasia 10.3 CDKN2A MKI67
35 nasal cavity squamous cell carcinoma 10.3 CDKN2A KRT8
36 gastrointestinal stromal tumor 10.3 CDKN2A MKI67 MTHFR
37 endocervicitis 10.3
38 benign meningioma 10.3 BIRC5 MKI67 TERT
39 adenocarcinoma in situ 10.2
40 basaloid squamous cell carcinoma 10.2 CDKN2A KRT17 KRT8
41 pre-malignant neoplasm 10.2 CDKN2A KRT17 KRT8
42 inverted papilloma 10.2 CDKN2A MKI67
43 tongue cancer 10.2 CDKN2A TERT VEGFC
44 blood group, i system 10.2
45 megaesophagus 10.2 CDKN2A FHIT
46 oral squamous cell carcinoma 10.2 CDKN2A KRT17 VEGFC
47 chlamydia 10.2
48 bacterial vaginosis 10.2
49 malignant glioma 10.2 BIRC5 CDKN2A TERT
50 retinoblastoma 10.1

Graphical network of the top 20 diseases related to Cervical Intraepithelial Neoplasia:



Diseases related to Cervical Intraepithelial Neoplasia

Symptoms & Phenotypes for Cervical Intraepithelial Neoplasia

GenomeRNAi Phenotypes related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

25
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) GR00104-A-0 8.8 CDC6 MKI67 RBL1

MGI Mouse Phenotypes related to Cervical Intraepithelial Neoplasia:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 mortality/aging MP:0010768 9.7 BIRC5 CDKN2A FHIT KRT17 KRT8 MTHFR
2 digestive/alimentary MP:0005381 9.63 KRT8 RBL1 TERT CDKN2A FHIT KRT17
3 neoplasm MP:0002006 9.02 CDKN2A FHIT NME1 RBL1 TERT

Drugs & Therapeutics for Cervical Intraepithelial Neoplasia

Drugs for Cervical Intraepithelial Neoplasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 195)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
2
Bupivacaine Approved, Investigational Phase 4 38396-39-3, 2180-92-9 2474
3
Aluminum hydroxide Approved, Investigational Phase 4,Phase 3 21645-51-2
4 Racepinephrine Approved Phase 4,Phase 3,Phase 2 329-65-7
5 Vaccines Phase 4,Phase 3,Phase 1,Phase 2
6 Anesthetics Phase 4,Phase 3,Phase 2
7 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1
8 Respiratory System Agents Phase 4,Phase 2
9 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
10 Adrenergic Agents Phase 4,Phase 2
11 Adrenergic Agonists Phase 4,Phase 2
12 Adrenergic alpha-Agonists Phase 4,Phase 2
13 Mydriatics Phase 4,Phase 2
14 Adrenergic beta-Agonists Phase 4,Phase 2
15 Neurotransmitter Agents Phase 4,Phase 2
16 Vasoconstrictor Agents Phase 4,Phase 2
17 Hormone Antagonists Phase 4,Phase 2
18 Anesthetics, Local Phase 4,Phase 3,Phase 2
19 Hormones Phase 4,Phase 2
20 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2
21 Anti-Asthmatic Agents Phase 4,Phase 2
22 Epinephryl borate Phase 4,Phase 3,Phase 2
23 Estrogens Phase 4
24 Estrogens, Conjugated (USP) Phase 4
25 Autonomic Agents Phase 4,Phase 2
26 Bronchodilator Agents Phase 4,Phase 2
27 Monophosphoryl lipid A Phase 4
28
Imiquimod Approved, Investigational Phase 2, Phase 3, Phase 1 99011-02-6 57469
29
Menthol Approved Phase 2, Phase 3 2216-51-5 16666
30
Lidocaine Approved, Vet_approved Phase 3,Phase 2 137-58-6 3676
31
Isotretinoin Approved Phase 3 4759-48-2 5282379 5538
32
Fluorouracil Approved Phase 3,Phase 1 51-21-8 3385
33
Aluminum sulfate Approved Phase 3 10043-01-3
34
acetic acid Approved, Nutraceutical Phase 3,Phase 1 64-19-7 176
35
leucovorin Approved, Nutraceutical Phase 3,Phase 2 58-05-9 143 6006
36
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2 59-30-3 6037
37
Fenretinide Investigational Phase 3 65646-68-6
38
3,3'-diindolylmethane Investigational Phase 3 1968-05-4
39
Retinol acetate Phase 3,Phase 1 127-47-9 10245972
40 interferons Phase 2, Phase 3, Phase 1
41 Adjuvants, Immunologic Phase 2, Phase 3, Phase 1
42 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
43 Anti-Infective Agents Phase 3,Phase 2,Phase 1,Early Phase 1
44 Immunoglobulins Phase 3,Phase 1
45 Interferon Inducers Phase 2, Phase 3, Phase 1
46 Protective Agents Phase 3,Phase 1,Phase 2
47 Antibodies Phase 3,Phase 1
48 Antiviral Agents Phase 3,Phase 2,Phase 1
49 Retinamide Phase 3
50 Micronutrients Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 329)

# Name Status NCT ID Phase Drugs
1 Can Alternative Treatment Have an Impact on Cervical Dysplasia? Unknown status NCT00842738 Phase 4
2 Management of Cervical Intraepithelial Neoplasia Grade 2 Completed NCT00733109 Phase 4
3 V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) Completed NCT01544478 Phase 4
4 Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization Completed NCT02368054 Phase 4 Bupivacaine;Adrenaline
5 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
6 Effect of Hormone Replacement Therapy on Lupus Activity Completed NCT00392093 Phase 4 Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
7 HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions Recruiting NCT03051516 Phase 4
8 The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Active, not recruiting NCT02629510 Phase 4 Tachosil
9 FASTER-Tlalpan Study Active, not recruiting NCT03105856 Phase 4
10 CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening (CITRUS Study) Active, not recruiting NCT01895517 Phase 4
11 Effectiveness of Cervical Screening in HPV Vaccinated Women Enrolling by invitation NCT02149030 Phase 4
12 Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) Unknown status NCT01095198 Phase 2, Phase 3
13 ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial Completed NCT00941252 Phase 2, Phase 3 Topical imiquimod therapy
14 Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants Completed NCT00128661 Phase 3
15 Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia Completed NCT00212381 Phase 3 di indolylmethane (DIM)
16 Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial Completed NCT02330471 Phase 3
17 Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix Completed NCT02130323 Phase 2, Phase 3 Imiquimod
18 Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study Completed NCT00929526 Phase 3
19 Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit Completed NCT00237562 Phase 3
20 A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women Completed NCT00000758 Phase 3 Fluorouracil
21 Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) Completed NCT00092521 Phase 3
22 A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix Completed NCT00264732 Phase 2, Phase 3 Amolimogene;Amolimogene
23 Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial Completed NCT01505920 Phase 3
24 Fenretinide in Treating Patients With Cervical Neoplasia Completed NCT00003075 Phase 3 Fenretinide
25 A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins Completed NCT01929993 Phase 3
26 Diindolylmethane in Treating Patients With Abnormal Cervical Cells Completed NCT00462813 Phase 3 oral microencapsulated diindolylmethane
27 Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1 Completed NCT00156026 Phase 3
28 Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS) Completed NCT01131312 Phase 3
29 Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion Completed NCT00995020 Phase 3
30 Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women Completed NCT00337818 Phase 3
31 Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine Completed NCT00316706 Phase 3
32 Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015) Completed NCT00092534 Phase 3
33 Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention Completed NCT01014026 Phase 3
34 Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 Completed NCT00122681 Phase 3
35 Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects Completed NCT00779766 Phase 3
36 Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older Completed NCT00294047 Phase 3
37 A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls Completed NCT02562508 Phase 3
38 A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) Completed NCT00090220 Phase 3
39 Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors Completed NCT00001073 Phase 3 Isotretinoin
40 Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041) Completed NCT00834106 Phase 3
41 Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System Completed NCT00973362 Phase 3
42 Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol Recruiting NCT02669459 Phase 3 Imiquimod
43 REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) Recruiting NCT03185013 Phase 3
44 A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study Recruiting NCT03355820 Phase 3
45 The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection Recruiting NCT03366493 Phase 3
46 Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix Recruiting NCT02346227 Phase 3 AV2;Placebo
47 Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions Recruiting NCT02135419 Phase 3 imiquimod;fluorouracil
48 Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions Recruiting NCT02059499 Phase 3 imiquimod;fluorouracil
49 A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. Active, not recruiting NCT02733068 Phase 3
50 Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine Active, not recruiting NCT01735006 Phase 3

Search NIH Clinical Center for Cervical Intraepithelial Neoplasia

Genetic Tests for Cervical Intraepithelial Neoplasia

Anatomical Context for Cervical Intraepithelial Neoplasia

MalaCards organs/tissues related to Cervical Intraepithelial Neoplasia:

38
Testes, Cervix, T Cells, Skin, Bone, Kidney, Bone Marrow

Publications for Cervical Intraepithelial Neoplasia

Articles related to Cervical Intraepithelial Neoplasia:

(show top 50) (show all 804)
# Title Authors Year
1
Characteristic findings of high-grade cervical intraepithelial neoplasia or more on magnifying endoscopy with narrow band imaging. ( 29446041 )
2018
2
Early and late pregnancy outcomes in women treated with cold-coagulation versus LLETZ cervical treatment for cervical intraepithelial neoplasia; a retrospective cohort study. ( 29404740 )
2018
3
Depth of Cervical Intraepithelial Neoplasia Grade 3 in Peruvian Women: Implications for Therapeutic Depth of Necrosis. ( 29271853 )
2018
4
Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV. ( 29353074 )
2018
5
Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation. ( 29319498 )
2018
6
Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia. ( 29431861 )
2018
7
Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up. ( 29369205 )
2018
8
Prevalence of high-grade cervical intraepithelial neoplasia in women with persistent high-risk HPV genotypes and negative cytology. ( 29350424 )
2018
9
Programmed death-1 (PD-1) expression in cervical intraepithelial neoplasia and its relationship with recurrence after conization. ( 29400020 )
2018
10
Clinical outcomes after conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women ages 21-39 years. ( 29437696 )
2018
11
Medical Devices; Hematology and Pathology Devices; Classification of a Cervical Intraepithelial Neoplasia Test System. Final order. ( 29319946 )
2018
12
Risk of preterm birth in women with cervical intraepithelial neoplasia grade one: a population-based cohort study. ( 29165793 )
2018
13
Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis. ( 28832077 )
2017
14
Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status. ( 28833798 )
2017
15
Translation and cultural adaptation of the Functional Assessment of Chronic Illness Therapy - Cervical Dysplasia (FACIT-CD) to evaluate quality of life in women with cervical intraepithelial neoplasia. ( 28767912 )
2017
16
Development of a goat model for evaluation of withaferin A: Cervical implants for the treatment of cervical intraepithelial neoplasia. ( 29157955 )
2017
17
Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia? ( 28817235 )
2017
18
Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study. ( 29218720 )
2017
19
A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters. ( 27697590 )
2017
20
Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+). ( 29279588 )
2017
21
Type-Dependent Association between Risk of Cervical Intraepithelial Neoplasia and Viral Load of Oncogenic Human Papillomavirus Types Other than Types 16 and 18. ( 28052328 )
2017
22
Influence of co-infection complicated with human papillomavirus on cervical intraepithelial neoplasia development in patients with atypical squamous cells of undetermined significance. ( 28923300 )
2017
23
A retrospective analysis on 1901 women with high grade cervical intraepithelial neoplasia by colposcopic biopsy. ( 28850822 )
2017
24
Validity Parameters of the Human Papillomavirus Detection Test Hybrid Capture 2 With and Without Cytology After Laser Destruction and Large Loop Excision of the Transformation Zone Treatment of High-Grade Cervical Intraepithelial Neoplasia Lesions. ( 28953121 )
2017
25
Cervical intraepithelial neoplasia (CIN) 3-like squamous cell carcinoma of the cervix: a review of 14 cases with comparison of E-cadherin and cyclin D1 expression in the CIN 3-like and infiltrative tumour elements. ( 27681166 )
2017
26
The Neutrophil-Lymphocyte Ratio Predicts Recurrence of Cervical Intraepithelial Neoplasia. ( 28819422 )
2017
27
The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap. ( 28756395 )
2017
28
Digital Colposcopy With Dynamic Spectral Imaging for Detection of Cervical Intraepithelial Neoplasia 2+ in Low-Grade Referrals: The IMPROVE-COLPO Study. ( 28953107 )
2017
29
Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer. ( 28785305 )
2017
30
Authors' reply re: Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study. ( 28921796 )
2017
31
Expression of p16INK4A Protein in Cervical Intraepithelial Neoplasia and Invasive Carcinoma of Uterine Cervix. ( 29207716 )
2017
32
Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome. ( 28705710 )
2017
33
Perceived cervical cancer risk among women treated for high-grade cervical intraepithelial neoplasia: The importance of specific knowledge. ( 29272293 )
2017
34
Influence of Human Papillomavirus Infection on the Natural History of Cervical Intraepithelial Neoplasia 1: A Meta-Analysis. ( 28812024 )
2017
35
Nanomechanical Characteristics of Cervical Cancer and Cervical Intraepithelial Neoplasia Revealed by Atomic Force Microscopy. ( 28859048 )
2017
36
Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran. ( 28786495 )
2017
37
Expression of p63, p53 and Ki-67 in Patients with Cervical Intraepithelial Neoplasia. ( 28044307 )
2017
38
Lower Incidence of Cervical Intraepithelial Neoplasia among Young Women with Human Papillomavirus Vaccination in Miyagi, Japan. ( 29269635 )
2017
39
A pilot study on Hla-G locus control region haplotypes and cervical intraepithelial neoplasias. ( 27998803 )
2017
40
Loop Electrosurgical Excision Procedure<i>vs</i>. Cold Knife Cone in Treatment of Cervical Intraepithelial Neoplasia: Review of 447 Cases. ( 29263039 )
2017
41
Increased Cervical HIV RNA Shedding Among HIV-Infected Women Randomized to Loop Electrosurgical Excision Procedure (LEEP) compared to Cryotherapy for Cervical Intraepithelial Neoplasia 2/3. ( 29272368 )
2017
42
Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial. ( 28050798 )
2017
43
Bacterial Vaginosis and Cervical Intraepithelial Neoplasia: Is there an Association or is Co-Existence Incidental? ( 28610416 )
2017
44
Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in South African HIV-infected women: a randomized, controlled trial. ( 28902073 )
2017
45
LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia. ( 28854904 )
2017
46
Re: Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study. ( 28921789 )
2017
47
The use of cold coagulation for the treatment of cervical intraepithelial neoplasia. ( 28737306 )
2017
48
Silent High Grade Cervical Intraepithelial Neoplasia in Atypical Smears from Liquid Based Cervical Cytology - Three Years Experience in Thammasat University Hospital. ( 27797243 )
2016
49
Obstetric complications after treatment of cervical intraepithelial neoplasia. ( 27487072 )
2016
50
Evaluation of careHPV, Cervista Human Papillomavirus, and Hybrid Capture 2 Methods in Diagnosing Cervical Intraepithelial Neoplasia Grade 2+ in Xinjiang Uyghur Women. ( 27317575 )
2016

Variations for Cervical Intraepithelial Neoplasia

Expression for Cervical Intraepithelial Neoplasia

Search GEO for disease gene expression data for Cervical Intraepithelial Neoplasia.

Pathways for Cervical Intraepithelial Neoplasia

Pathways related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 12.08 BIRC5 CDKN2A TERC TERT VEGFC
2 10.83 BIRC5 NME1 ODC1 TERT

GO Terms for Cervical Intraepithelial Neoplasia

Cellular components related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytosol GO:0005829 9.32 BIRC5 CDC6 CDKN2A FHIT KRT17 KRT8
2 intermediate filament GO:0005882 9.13 KRT17 KRT8 NME1

Biological processes related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of cell proliferation GO:0008285 9.56 CDC6 CDKN2A NME1 VEGFC
2 nucleotide metabolic process GO:0009117 9.32 FHIT NME1
3 negative regulation of cellular senescence GO:2000773 9.16 RBL1 TERT
4 cell cycle GO:0007049 9.02 BIRC5 CDC6 CDKN2A MKI67 RBL1
5 replicative senescence GO:0090399 8.96 CDKN2A TERT

Sources for Cervical Intraepithelial Neoplasia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....